Hologic Inc.
Hologic Announces Merger Agreement and Faces Related Litigation
Summary
Hologic, Inc. has entered into a merger agreement with Hopper Parent Inc., under which Hopper Merger Sub Inc. will merge with and into Hologic, with Hologic surviving as a wholly owned subsidiary of Hopper Parent. The transaction is subject to various conditions and stockholder approval. In connection with the merger, several purported stockholders have filed class action lawsuits and individual actions against Hologic and its board of directors, alleging omissions in the proxy statement regarding the merger. Hologic believes the allegations are without merit but is supplementing the proxy statement to mitigate the risk of litigation delaying the merger. Additionally, Hologic has initiated a voluntary recall of its Brevera Breast Biopsy System Disposable 9 Gauge Needles due to safety concerns, which may impact financial results. The Company has also settled a product liability lawsuit related to its BioZorb 3D Bioabsorbable Marker, with the settlement amount covered by insurance.
Profitelligence Alerts
Get alerts for HOLX
Be first to know when Hologic Inc. files with the SEC.
Filing Categories
Advertisement
About Hologic Inc.
Hologic Inc. is a leading global medical technology company focused on improving women's health and well-being. Its primary function is to develop, manufacture, and supply diagnostic products, medical imaging systems, and surgical products, which play crucial roles in the prevention and treatment of diseases. Hologic's key sectors include breast health, diagnostics, gynecological surgical, and skeletal health solutions. It is renowned for innovative technologies such as 3D mammography or tomosynthesis, which are significant advancements in breast cancer detection. With a commitment to enhancing healthcare quality and efficiency, Hologic operates across a diverse range of healthcare settings, from hospitals and clinics to laboratories and research facilities. Headquartered in Marlborough, Massachusetts, Hologic has established itself as a pivotal player in women's health diagnostics, contributing to its substantial market presence and influence in the global healthcare sector.
Official SEC Documents
Advertisement